Effect of IL-6 and hsCRP Serum Levels on Functional Prognosis in Stroke Patients Undergoing IV-Thrombolysis: Retrospective Analysis.
Hanna PawlukGrzegorz GrześkRenata KołodziejskaMariusz KozakiewiczAlina WoźniakElżbieta GrzechowiakMaciej SzumnyPiotr SobolewskiLeszek BieniaszewskiGrzegorz M KozeraPublished in: Clinical interventions in aging (2020)
Regardless of the stroke etiology, pretreatment of IL-6, but not of hsCRP levels, may help to predict functional outcome after IV-thrombolysis independently of symptom severity and stroke complications.